@_APollack
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States App Store
Account-level information from X, not a live location or the device used for a specific post.
Chair and Professor of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Miami, FL
Joined June 2018
- Tweets15
- Following11
- Followers207
- Likes5
Alan Pollack, MD, PhD retweeted
Yes, GETUG AFU-16 and RTOG 9601 are the main complimentary randomized trials to the SPPORT trial. The GETUG trial is the most comparable, because both SPPORT and GETUG used short term ADT. All three trials showed outcome benefits from the addition of ADT to prostate bed RT.